| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
Oktober 2022 - 66 Präparate |
|
L | | FI | | | Decitabin Accord 50 mg | | 855.44 | 998.45 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
L | | FI | | | Decitabin Sandoz 50 mg | | 855.44 | 998.45 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
L | | FI | PI | | Bimzelx 160 mg | 2 | 2143.41 | 2412.30 | 10% | | Injektionslösung in Fertigspritze: Bimekizumabum 160mg / 1ml | UCB-Pharma SA | B / SL | FB | | G |  |
L | | FI | PI | | Bimzelx 160 mg | 2 | 2143.41 | 2412.30 | 10% | | solution injectable en seringue préremplie: Bimekizumabum 160mg / 1ml | UCB-Pharma SA | B / SL | FB | | G |  |
| | FI | PI | I/B | Comirnaty® Original/Omicron BA.1 15/15 µg pro Dosis gebrauchsfertige Injektionsdispersion für Personen ab 18 Jahren | 10 | PA | PA | k.A. | | 2 Wirkstoffe | Pfizer AG | B | FB | | G |  |
| | FI | PI | I/B | Comirnaty® Original/Omicron BA.1 15/15 µg pro Dosis gebrauchsfertige Injektionsdispersion für Personen ab 18 Jahren | 195 | PA | PA | k.A. | | 2 Wirkstoffe | Pfizer AG | B | FB | | G |  |
| | | | | Vantobra 170 mg | 56 | PA | PA | k.A. | | Inhalationslösung: Tobramycinum 170mg / 1.7ml | PARI Swiss AG | A | FB | | G |  |
| | FI | | I/B | MenQuadfi | | PA | PA | k.A. | | Injektionslösung: 4 Wirkstoffe | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | FI | | I/B | MenQuadfi | 5 | PA | PA | k.A. | | Injektionslösung: 4 Wirkstoffe | Sanofi-Aventis (Suisse) SA | B | FB | | G |  |
| | FI | PI | | Bimzelx 160 mg | | PA | PA | k.A. | | Injektionslösung in Fertigspritze: Bimekizumabum 160mg / 1ml | UCB-Pharma SA | B | FB | | G |  |
| | | | | Cabazitaxel-Teva 60 mg/6 ml | | PA | PA | k.A. | | Infusionskonzentrat: Cabazitaxelum 60mg / 6ml | Teva Pharma AG | A | FB | | G |  |
| | | | | Dexmedetomidine Baxter 200 μg/2 ml | 5 | PA | PA | k.A. | | Infusionskonzentrat: Dexmedetomidinum 200µg / 2ml | Baxter AG | A | FB | | G |  |
| | | | | Rapibloc 300 mg | | PA | PA | k.A. | | Lyophilisat: Landiololi Hydrochloridum 300 mg | OrPha Swiss GmbH | B | FB | | G |  |
| | | | | Rivaroxaban Sandoz vascular 2,5 mg | 10 | PA | PA | k.A. | | Filmtabletten: Rivaroxabanum 2.5 mg | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Rivaroxaban Sandoz vascular 2,5 mg | 30 | PA | PA | k.A. | | Filmtabletten: Rivaroxabanum 2.5 mg | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Rivaroxaban Sandoz vascular 2,5 mg | 56 | PA | PA | k.A. | | Filmtabletten: Rivaroxabanum 2.5 mg | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Rivaroxaban Sandoz vascular 2,5 mg | 100 | PA | PA | k.A. | | Filmtabletten: Rivaroxabanum 2.5 mg | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Rivaroxaban Sandoz vascular 2,5 mg | 196 | PA | PA | k.A. | | Filmtabletten: Rivaroxabanum 2.5 mg | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Sitagliptin Xiromed 25 mg | 28 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 25 mg | Xiromed SA | B | FB | | G |  |
| | | | | Sitagliptin Xiromed 25 mg | 98 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 25 mg | Xiromed SA | B | FB | | G |  |
| | | | | Sitagliptin Xiromed 25 mg | 100 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 25 mg | Xiromed SA | B | FB | | G |  |
| | | | | Sitagliptin Xiromed 50 mg | 28 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 50 mg | Xiromed SA | B | FB | | G |  |
| | | | | Sitagliptin Xiromed 50 mg | 98 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 50 mg | Xiromed SA | B | FB | | G |  |
| | | | | Sitagliptin Xiromed 50 mg | 100 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 50 mg | Xiromed SA | B | FB | | G |  |
| | | | | Sitagliptin Xiromed 100 mg | 28 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 100 mg | Xiromed SA | B | FB | | G |  |
| | | | | Sitagliptin Xiromed 100 mg | 98 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 100 mg | Xiromed SA | B | FB | | G |  |
| | | | | Sitagliptin Xiromed 100 mg | 100 | PA | PA | k.A. | | Filmtabletten: Sitagliptinum 100 mg | Xiromed SA | B | FB | | G |  |
| | | | | Perindopril/Amlodipin Viatris 4 mg/5 mg | 30 | PA | PA | k.A. | | Tabletten: 2 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Perindopril/Amlodipin Viatris 4 mg/5 mg | 90 | PA | PA | k.A. | | Tabletten: 2 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Perindopril/Amlodipin Viatris 8 mg/5 mg | 30 | PA | PA | k.A. | | Tabletten: 2 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Perindopril/Amlodipin Viatris 8 mg/5 mg | 90 | PA | PA | k.A. | | Tabletten: 2 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Perindopril/Amlodipin Viatris 4 mg/10mg | 30 | PA | PA | k.A. | | Tabletten: 2 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Perindopril/Amlodipin Viatris 4 mg/10mg | 90 | PA | PA | k.A. | | Tabletten: 2 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Perindopril/Amlodipin Viatris 8 mg/10 mg | 30 | PA | PA | k.A. | | Tabletten: 2 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | | Perindopril/Amlodipin Viatris 8 mg/10 mg | 90 | PA | PA | k.A. | | Tabletten: 2 Wirkstoffe | Mylan Pharma GmbH | B | FB | | G |  |
| | | | CM | Vildagliptin Sandoz 50 mg | 28 | PA | PA | k.A. | | Tabletten: Vildagliptinum 50 mg | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | CM | Vildagliptin Sandoz 50 mg | 112 | PA | PA | k.A. | | Tabletten: Vildagliptinum 50 mg | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Vitamin D3 Sandoz eco 1000 I.E. | 30 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 1000 UI | Sandoz Pharmaceuticals AG | D | FB | | G |  |
| | | | | Vitamin D3 Sandoz eco 1000 I.E. | 90 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 1000 UI | Sandoz Pharmaceuticals AG | D | FB | | G |  |
| | | | | Vitamin D3 Sandoz eco 3200 I.E. | 30 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 3200 UI | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Vitamin D3 Sandoz eco 3200 I.E. | 90 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 3200 UI | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Vitamin D3 Sandoz eco 25000 I.E. | 4 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 25000 UI | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Vitamin D3 Sandoz eco 25000 I.E. | 8 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 25000 UI | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Vitamin D3 Sandoz eco 25000 I.E. | 12 | PA | PA | k.A. | | Weichkapseln: Cholecalciferolum 25000 UI | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | | | | Klostergarten Brusttee Hieronymus N | 20 x 1.5 g | PA | PA | k.A. | | Arzneitee: 6 Wirkstoffe | Migros- Genossenschafts-Bund | E | FB | | G |  |
| | FI | | | Pretuval Halsschmerzen | 20 | PA | PA | k.A. | | Lutschtabletten mit Honig-Orangenaroma: Benzydamini Hydrochloridum 3 mg | Bayer (Schweiz) AG | D | FB | | G |  |
| | FI | | | Pretuval Halsschmerzen | 20 | PA | PA | k.A. | | Lutschtabletten mit Zitronenaroma: Benzydamini Hydrochloridum 3 mg | Bayer (Schweiz) AG | D | FB | | G |  |
| | | | | Decitabine Ideogen 50 mg | | PA | PA | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mg | Ideogen AG | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini 0,02 mg | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini 0,02 mg | 21 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini 0,02 mg | 48 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini 0,2 mg | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini 0,2 mg | 21 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini 0,2 mg | 48 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini 2 mg | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini 2 mg | 21 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini 2 mg | 48 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini 20 mg | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) 1 ml | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini D6 | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Viscum Album Fraxini ex Herba Recente col. D6 (Hab 32) 1 ml | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini D10 | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Viscum Album Fraxini ex Herba Recente col. D10 (Hab 32) 1 ml | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini D20 | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Viscum Album Fraxini ex Herba Recente col. D20 (Hab 32) 1 ml | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini D30 | 8 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Viscum Album Fraxini ex Herba Recente col. D30 (Hab 32) 1 ml | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini 20 mg | 21 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) 1 ml | Future Health Pharma GmbH | A | FB | | G |  |
| | | | | abnobaVISCUM Fraxini 20 mg | 48 x 1 ml | PA | PA | k.A. | | anthroposophisches Arzneimittel: Visci albi Fraxini Herbae Recentis Extractum Liquidum (Viscum Album ssp. Album l., Herba; Wirtsbaum: Fraxinus Excelsior l., Fraxinus Angustifolia vahl oder ihre Hybriden) 1 ml | Future Health Pharma GmbH | A | FB | | G |  |
| | FI | PI | | Bimzelx 160 mg | | PA | PA | k.A. | | solution injectable en seringue préremplie: Bimekizumabum 160mg / 1ml | UCB-Pharma SA | B | FB | | G |  |
| | | | I/B | Spikevax | 10 | PA | PA | k.A. | | | Moderna Switzerland GmbH | B | FB | | G |  |